About Brad

Brad Sanderson joined Integria of Head of Scientific & Clinical Affairs in October 2026.

He brings more than 20 years of leadership experience across complementary medicines, consumer health, pharmaceuticals and digital health, having worked across Australia, Asia and Europe.

Throughout his career, Brad has successfully connected scientific research, clinical evidence, product innovation and commercial strategy to deliver meaningful outcomes for healthcare practitioners and consumers. He has led innovation, evidence generation and research programs, translated scientific insights into commercially successful products, and built strong partnerships across industry, healthcare and academic sectors.

Brad is passionate about science-led innovation, practitioner trust and building high-performing teams. He is committed to advancing evidence-based healthcare solutions, strengthening Integria's scientific capabilities, and supporting healthcare practitioners with trusted products, education and clinical support.